These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30187136)

  • 1. Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats.
    Castoldi G; di Gioia CRT; Roma F; Carletti R; Manzoni G; Stella A; Zerbini G; Perseghin G
    Acta Diabetol; 2019 Jan; 56(1):97-104. PubMed ID: 30187136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats.
    Castoldi G; di Gioia CR; Bombardi C; Maestroni S; Carletti R; Steckelings UM; Dahlöf B; Unger T; Zerbini G; Stella A
    Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1123-31. PubMed ID: 25186297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension.
    Castoldi G; Carletti R; Ippolito S; Stella A; Zerbini G; Pelucchi S; Zatti G; di Gioia CRT
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats.
    Rehman A; Leibowitz A; Yamamoto N; Rautureau Y; Paradis P; Schiffrin EL
    Hypertension; 2012 Feb; 59(2):291-9. PubMed ID: 22184324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sitagliptin Protects Cardiac Function by Reducing Nitroxidative Stress and Promoting Autophagy in Zucker Diabetic Fatty (ZDF) Rats.
    Zhou Y; Wang H; Man F; Guo Z; Xu J; Yan W; Li J; Pan Q; Wang W
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):541-552. PubMed ID: 30328028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway.
    Korkmaz-Icöz S; Al Said S; Radovits T; Li S; Brune M; Hegedűs P; Atmanli A; Ruppert M; Brlecic P; Lehmann LH; Lahrmann B; Grabe N; Yoshikawa Y; Yasui H; Most P; Karck M; Szabó G
    Cardiovasc Diabetol; 2016 May; 15():75. PubMed ID: 27153943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible synergistic effect of direct angiotensin II type 2 receptor stimulation by compound 21 with memantine on prevention of cognitive decline in type 2 diabetic mice.
    Iwanami J; Mogi M; Tsukuda K; Jing F; Ohshima K; Wang XL; Nakaoka H; Kan-no H; Chisaka T; Bai HY; Min LJ; Horiuchi M
    Eur J Pharmacol; 2014 Feb; 724():9-15. PubMed ID: 24361310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic NF-κB blockade improves renal angiotensin II type 1 receptor functions and reduces blood pressure in Zucker diabetic rats.
    Luo H; Wang X; Wang J; Chen C; Wang N; Xu Z; Chen S; Zeng C
    Cardiovasc Diabetol; 2015 Jun; 14():76. PubMed ID: 26055622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression.
    Li C; Cao L; Zeng Q; Liu X; Zhang Y; Dai T; Hu D; Huang K; Wang Y; Wang X; Li D; Chen Z; Zhang J; Li Y; Sharma R
    Cardiovasc Drugs Ther; 2005 Mar; 19(2):105-12. PubMed ID: 16025228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis.
    Chow BS; Koulis C; Krishnaswamy P; Steckelings UM; Unger T; Cooper ME; Jandeleit-Dahm KA; Allen TJ
    Diabetologia; 2016 Aug; 59(8):1778-90. PubMed ID: 27168137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor.
    Huang TH; He L; Qin Q; Yang Q; Peng G; Harada M; Qi Y; Yamahara J; Roufogalis BD; Li Y
    Diabetes Obes Metab; 2008 Jul; 10(7):574-85. PubMed ID: 17645561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes.
    Oltman CL; Kleinschmidt TL; Davidson EP; Coppey LJ; Lund DD; Yorek MA
    Vascul Pharmacol; 2008 Jan; 48(1):47-53. PubMed ID: 18164667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM; Risovic V; Yuen VG; McNeill JH
    J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats.
    Suzaki Y; Ozawa Y; Kobori H
    Int J Biol Sci; 2006 Nov; 3(1):40-6. PubMed ID: 17200690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yunpi Heluo decoction attenuates insulin resistance by regulating liver miR-29a-3p in Zucker diabetic fatty rats.
    Mao ZJ; Weng SY; Lin M; Chai KF
    J Ethnopharmacol; 2019 Oct; 243():111966. PubMed ID: 31128151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Benzofuran
    Costa GC; Montagnoli TL; Da Silva JS; de Alencar AKN; Reina Gamba LE; Alves BEO; da Silva MMC; Trachez MM; do Nascimento JHM; Pimentel-Coelho PM; Mendez-Otero R; Lima LM; Barreiro EJ; Sudo RT; Zapata-Sudo G
    Drug Des Devel Ther; 2020; 14():3337-3350. PubMed ID: 32884238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia-reperfusion necrosis in rats.
    Ozhan O; Parlakpinar H; Acet A
    Fundam Clin Pharmacol; 2021 Aug; 35(4):669-680. PubMed ID: 32810901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats.
    Ali Q; Patel S; Hussain T
    Am J Physiol Renal Physiol; 2015 Jun; 308(12):F1379-85. PubMed ID: 25855512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes.
    Ramírez E; Klett-Mingo M; Ares-Carrasco S; Picatoste B; Ferrarini A; Rupérez FJ; Caro-Vadillo A; Barbas C; Egido J; Tuñón J; Lorenzo Ó
    Cardiovasc Diabetol; 2013 Nov; 12():172. PubMed ID: 24261558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.